Stockscreener 앱 받기
4.71
1.44%
-0.07
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Oral Mucositis Market Outlook: Trends & Forecast 2024-2031 | - openPR.com
Bausch health outlines 2025 guidance with 4-5% revenue and EBITDA growth amid strategic refinancing - MSN
Scar Treatment Market Detailed In New Research Report 2025 | - openPR.com
Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - Insider Monkey
Bausch Health shares fall 39% following InvestingPro’s overvalued warning By Investing.com - Investing.com
Bausch + Lomb Brief: Says Received European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens - marketscreener.com
Bausch Health (BHC) Data Highlights Reduced Rehospitalization wi - GuruFocus
Bausch Health (BHC) Data Highlights Reduced Rehospitalization with Xifaxan Use | BHC Stock News - GuruFocus
Bausch Health Up 3.5% In US Premarket As Says New Analysis Suggests efficacy of Xifaxan - marketscreener.com
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization - voiceofalexandria.com
Bausch Health (BHC) Target Price Reduced by Raymond James | BHC Stock News - GuruFocus
Bausch Health (BHC) Faces Revised Price Target by Raymond James | BHC Stock News - GuruFocus
Bausch Health price target cut to $8 by Raymond James - Investing.com Nigeria
Dry Eye Syndrome Treatment Market Set to Witness Significant - openPR.com
BHC: RBC Capital Raises Price Target for Bausch Health Companies - GuruFocus
Bausch Health Companies Inc. (NYSE:BHC) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Humana (HUM) and Larimar Therapeutics (LRMR) - The Globe and Mail
Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Psoriasis Market: Epidemiology, Therapies, Companies, - openPR.com
RBC on Bausch Health's Q1 - marketscreener.com
Bausch Health Q1 Earnings And Revenues Miss Estimates, Stock Down - Barchart.com
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down - Zacks Investment Research
Bausch Health Companies Inc. SEC 10-Q Report - TradingView
Bausch: Q1 Earnings Snapshot - The Washington Post
Bausch Health Reports Q1 2025 Financial Results - TipRanks
Bausch Health Companies Q1 2025 Earnings Call Transcript - MarketBeat
Bausch Health (BHC) Q1 Earnings and Revenues Lag Estimates - Yahoo Finance
Bausch (BHC) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Bausch Health Companies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Bausch Health Q1 2025 slides: revenue up 6%, EBITDA grows 14% excluding B+L - Investing.com
Bausch Health Companies Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:BHC) - Seeking Alpha
Bausch Health Down 3.8% After Hours as It Reports a Lower Q1 Adjusted Profit - marketscreener.com
Bausch Health Reports Strong Q1 2025 Results with Revenue Growth and Strategic Refinancing - TipRanks
Bausch Health (BHC) Pre-Earnings Options Activity Indicates Anti - GuruFocus
Bausch Health Reports 8th Consecutive Growth Quarter, Completes $7.9B Refinancing Deal - Stock Titan
Bausch Health Announces First Quarter 2025 Results - The Globe and Mail
Bausch + Lomb Brief: Updating FY25 Guidance to Reflect Estimated One-Time Impact of enVista Intraocular Lenses Voluntary Recall and Impact of FX - marketscreener.com
Health Canada approves Bausch Health’s skin tightening device - Investing.com
Bausch Health Companies Q1 2025 Earnings Preview - MSN
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Bausch Health Companies Inc. (BHC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Hyperopia Market, Epidemiology, Therapies, Companies, - openPR.com
Bausch Health's Skin Tightening System Gets Health Canada Clearance - marketscreener.com
BHC Receives Canadian Approval for Advanced Thermage FLX Device - GuruFocus
Bausch Health Announcing Health Canada Clearance of Solta Medical's Thermage FLX System - marketscreener.com
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System - voiceofalexandria.com
Revolutionary Skin Tightening Device Thermage FLX Gets Health Canada Green Light: 25% Faster Treatments - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Onychomycosis Drug Market Emerging Trends and Growth Prospects - openPR.com
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares - MSN
Bausch Health jumps after Carl Icahn’s 34% stake - MSN
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc. - ACCESS Newswire
4.18%
0.04%
자본화:
|
볼륨(24시간):